Delivery Order SPE2DB20D7061-SPE2DB24FSPG4

Award Date 8/1/24
Potential Completion Date 8/2/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,461.44 Firm Fixed Price delivery order is for the supply of EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. The contract has an ultimate completion date of January 9, 2025. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,439.28 firm fixed-price delivery order is for EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a critical medical supply. The award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,980.34 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of 4565481765 EPINEPHRINE 1 MG/10 ML LUERJET 10ML, with an ultimate completion date of August 19, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA to...
This federal contract award, valued at $1,554.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of epinephrine 1 mg/10 ml Luerjet 10 ml, a critical medical commodity used in healthcare settings. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,558.20 delivery order is for the supply of 4565912433 EPINEPHRINE 1 MG/10 ML LUERJET 10ML, with an ultimate completion date of September 25, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a delivery order valued at $1,247.32 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of 4566527459 ! EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. The contract is a Firm Fixed Price delivery order under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,172.00, is for the delivery of EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. This is a Firm Fixed Price Delivery Order contract with a period of performance through January 13, 2025. The contract does not have any set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of EPINEPHRINE 1 MG/10 ML LUERJET 10ML medical products. The contract has a ceiling value of $1,511.64 and runs through November 18, 2024. This is a delivery order contract with firm-fixed pricing. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,175.72 firm-fixed-price delivery order is for the supply of 4565477012 - EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for delivering...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,303.20 firm fixed-price contract is for the delivery of EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a critical medical product. The contract has an ultimate completion date of December 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB24FSPG4
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,436.06 firm fixed-price delivery order is for the supply of 4565313150 - EPINEPHRINE 1 MG/10 ML LUERJET 10ML, a critical medical product. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation and the ultimate completion date is August 2, 2024.

Generated 10/31/24, 9:56 AM